Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply issues

Government would give freight capacity to medicines over food additives after no-deal Brexit

The government is to prioritise freight capacity for importing medicines and medical devices over “critical food chain dependencies” in the event of a no-deal Brexit.

According to a list published by the Department of Health and Social Care (DHSC), “category 1” goods, which are described as “critical to preservation of human or animal welfare and/or national security”, will be imported through the short straits between Dover, Folkestone, Calais, Dunkirk, and Coquelles using government-secured freight capacity.

The list of goods which are “within consideration of the government-secured freight capacity” includes prescription-only, pharmacy and general sales list medicines, as well as vaccines and biological materials, such as blood, organs, tissues and cells.

The document also includes a list of category 1 goods that “are not considered to require access to government-secured freight capacity at this stage”, including “critical food chain dependencies”.

The document describes these products as chemicals and “key additives” used in the food supply chain.

The DHSC previously said on 25 February 2019 in a written statement to parliament that 7,000 prescription-only and pharmacy medicines have been subject to government planning for a no-deal Brexit, with companies supplying the drugs asked to maintain a six-week buffer stock in the UK.

But in a letter to medicines suppliers dated 18 February 2019, the DHSC said it recognises “that not all suppliers of medical devices and clinical consumables have the capability to hold stock of their full product range in the UK” and set up a dedicated shipping channel to ferry in urgent stocks.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20206275

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.